Semaglutide promote weight loss and help patients lose weight through mimicking the action of GLP-1, a hormone that regulates insulin secretion, inhibits glucagon release, and promotes feelings of fullness, ultimately leading to reduced food intake
DQSA separated compounding pharmacies into two categories: 503A pharmacies (your local compounding pharmacies) only dispense to patients within a single state
PubMed Central (PMC) , Hodson, Leanne, et al
"The Medicare GLP-1 Bridge program is a significant step forward for people living with obesity who have long faced barriers to access under Medicare," said Joe Nadglowski, President and CEO of the Obesity Action Coalition (OAC)
First, being a retrospective observational study conducted at a single center using historical data, the study is susceptible to confounding factors and biases